EMERYVILLE, Calif., April 23, 2010 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE-AMEX:NBY), a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today announced that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will deliver a corporate presentation at the BIO 2010 International Convention on Tuesday, May 4 at McCormick Place Convention Center in Chicago.
